Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity — Stella

Recruiting

Back to Obesity, Morbid trials

Trial locations(1 site)

United States

Mayo Clinic in Arizona, Scottsdale, Arizona

Key details

Sponsor

Mayo Clinic

Enrollment target

~60 participants

Started

February 2022

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

30 Years – 70 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov